Dr. Daniela Saadia, MD

NPI: 1629271390
Total Payments
$11,772
2024 Payments
$2,257
Companies
55
Transactions
621
Medicare Patients
5,681
Medicare Billing
$930,068

Payment Breakdown by Category

Food & Beverage$11,139 (94.6%)
Education$504.81 (4.3%)
Other$127.95 (1.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $11,139 607 94.6%
Education $504.81 6 4.3%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $127.95 8 1.1%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $1,106 68 $0 (2024)
Teva Pharmaceuticals USA, Inc. $874.26 28 $0 (2024)
Lilly USA, LLC $803.42 33 $0 (2024)
Amgen Inc. $728.88 27 $0 (2022)
Lundbeck LLC $683.05 37 $0 (2024)
UCB, Inc. $587.62 18 $0 (2024)
Alexion Pharmaceuticals, Inc. $444.32 18 $0 (2024)
Amneal Pharmaceuticals LLC $434.97 29 $0 (2024)
Allergan, Inc. $359.76 24 $0 (2022)
Supernus Pharmaceuticals, Inc. $357.45 24 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,257 116 ABBVIE INC. ($382.48)
2023 $2,112 95 AbbVie Inc. ($360.54)
2022 $1,510 84 ABBVIE INC. ($201.96)
2021 $1,529 95 Lundbeck LLC ($180.68)
2020 $1,175 68 Amgen Inc. ($188.94)
2019 $1,108 53 Amgen Inc. ($178.78)
2018 $1,235 48 Adamas Pharmaceuticals, Inc. ($173.92)
2017 $846.54 62 Teva Pharmaceuticals USA, Inc. ($235.89)

All Payment Transactions

621 individual payment records from CMS Open Payments — Page 1 of 25

Date Company Product Nature Form Amount Type
12/16/2024 Amneal Pharmaceuticals LLC CREXONT (Drug) Food and Beverage In-kind items and services $14.54 General
Category: NEUROLOGY
12/10/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $21.82 General
Category: Rare Disease
12/05/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $20.56 General
Category: NEUROSCIENCE
12/05/2024 SCILEX PHARMACEUTICALS INC. ZTLido (Drug) Food and Beverage In-kind items and services $16.10 General
Category: Analgesic
12/04/2024 Eisai Inc. Leqembi (Drug) Food and Beverage In-kind items and services $21.21 General
Category: Neurology
11/19/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $19.44 General
Category: BOTOX THERAPEUTIC
11/18/2024 Amneal Pharmaceuticals LLC ONGENTYS (Drug) Food and Beverage In-kind items and services $14.08 General
Category: NEUROLOGY
11/15/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $14.35 General
Category: PAIN
11/13/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $11.30 General
Category: NEUROSCIENCE
11/12/2024 REVANCE THERAPEUTICS, INC. DAXXIFY (Drug) Food and Beverage In-kind items and services $13.57 General
Category: AESTHETICS AND THERAPEUTICS
11/08/2024 Lilly USA, LLC AMYVID (Drug), KISUNLA Food and Beverage In-kind items and services $28.46 General
Category: Neuroscience
11/01/2024 PFIZER INC. PANZYGA (Biological) Food and Beverage In-kind items and services $16.73 General
Category: IMMUNOLOGY;INFLAMMATION
10/28/2024 Takeda Pharmaceuticals U.S.A., Inc. HYQVIA (Biological) Food and Beverage In-kind items and services $15.49 General
Category: IMMUNOLOGY
10/26/2024 ARGENX US, INC. VYVGART HYTRULO (Drug), VYVGART Food and Beverage In-kind items and services $14.31 General
Category: Neurology
10/22/2024 Lilly USA, LLC EMGALITY (Drug) Food and Beverage In-kind items and services $18.92 General
Category: Neuroscience
10/21/2024 Merz Pharmaceuticals, LLC INBRIJA (Drug), Xeomin Food and Beverage In-kind items and services $18.16 General
Category: Parkinson's Disease
10/16/2024 Eisai Inc. Leqembi (Drug) Food and Beverage In-kind items and services $16.78 General
Category: Neurology
10/16/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $15.32 General
Category: NEUROSCIENCE
10/12/2024 SCILEX PHARMACEUTICALS INC. ZTLido (Drug) Food and Beverage In-kind items and services $21.27 General
Category: Analgesic
10/07/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $22.04 General
Category: NEUROSCIENCE
10/05/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $15.29 General
Category: Neuropsychiatry
10/05/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $4.07 General
Category: Neuropsychiatry
09/30/2024 Amneal Pharmaceuticals LLC ONGENTYS 50MG CAPSULES 30 (Drug) Food and Beverage In-kind items and services $19.42 General
Category: NEUROLOGY
09/26/2024 Lilly USA, LLC KISUNLA (Drug) Food and Beverage Cash or cash equivalent $122.55 General
Category: Neuroscience
09/25/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $15.36 General
Category: BOTOX THERAPEUTIC

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 17 1,205 9,862 $309,865 $204,606
2022 16 1,279 12,690 $330,825 $221,937
2021 18 1,558 15,648 $406,645 $278,750
2020 17 1,639 13,447 $342,960 $224,775
Total Patients
5,681
Total Services
51,647
Medicare Billing
$930,068
Procedure Codes
68

All Medicare Procedures & Services

68 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 486 933 $135,325 $89,204 65.9%
J0585 Injection, onabotulinumtoxina, 1 unit Office 2023 12 8,095 $55,665 $40,008 71.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 137 137 $25,345 $17,413 68.7%
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Office 2023 126 182 $22,750 $14,174 62.3%
95910 Nerve conduction, 7-8 studies Office 2023 71 71 $15,975 $9,696 60.7%
95909 Nerve conduction, 5-6 studies Office 2023 73 73 $12,775 $7,963 62.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 76 86 $8,600 $5,284 61.4%
95911 Nerve conduction, 9-10 studies Office 2023 28 28 $7,700 $4,780 62.1%
95885 Needle measurement of electrical activity in arm or leg muscles, limited study Office 2023 59 93 $6,975 $4,660 66.8%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 29 29 $7,250 $4,519 62.3%
96132 Evaluation of neuropsychological test, first hour Office 2023 18 18 $2,970 $1,752 59.0%
11104 Punch biopsy, first skin growth Office 2023 13 13 $1,950 $1,360 69.7%
11105 Punch biopsy, each additional skin growth Office 2023 13 26 $1,950 $1,288 66.1%
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and Office 2023 16 18 $1,080 $771.66 71.5%
G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a Office 2023 12 23 $1,150 $752.62 65.4%
96139 Administration of psychological or neuropsychological test by technician, each additional 30 minutes Office 2023 18 19 $1,235 $510.85 41.4%
96138 Administration of psychological or neuropsychological test by technician, first 30 minutes Office 2023 18 18 $1,170 $468.86 40.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 457 833 $120,785 $78,114 64.7%
J0585 Injection, onabotulinumtoxina, 1 unit Office 2022 20 10,900 $70,850 $53,375 75.3%
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Office 2022 172 259 $32,375 $21,011 64.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 111 111 $20,535 $15,230 74.2%
95910 Nerve conduction, 7-8 studies Office 2022 84 84 $18,900 $11,576 61.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 117 142 $14,200 $9,273 65.3%
95909 Nerve conduction, 5-6 studies Office 2022 83 84 $14,700 $9,248 62.9%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 44 44 $11,000 $7,071 64.3%

About Dr. Daniela Saadia, MD

Dr. Daniela Saadia, MD is a Neurology healthcare provider based in Stuart, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1629271390.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniela Saadia, MD has received a total of $11,772 in payments from pharmaceutical and medical device companies, with $2,257 received in 2024. These payments were reported across 621 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($11,139).

As a Medicare-enrolled provider, Saadia has provided services to 5,681 Medicare beneficiaries, totaling 51,647 services with total Medicare billing of $930,068. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Location Stuart, FL
  • Active Since 06/08/2007
  • Last Updated 02/26/2015
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1629271390

Products in Payments

  • Aimovig (Biological) $720.40
  • Briviact (Drug) $498.07
  • BOTOX (Biological) $465.56
  • UBRELVY (Drug) $455.23
  • QULIPTA (Drug) $444.00
  • RYTARY (Drug) $431.67
  • ULTOMIRIS (Biological) $424.77
  • TROKENDI XR (Drug) $357.45
  • EMGALITY (Drug) $351.12
  • AMYVID (Drug) $329.75
  • Leqembi (Drug) $301.26
  • VYEPTI (Biological) $293.56
  • INGREZZA (Drug) $289.69
  • NURTEC ODT (Drug) $283.77
  • NUEDEXTA (Drug) $282.33
  • APTIOM (Drug) $282.21
  • NORTHERA (Drug) $270.99
  • AUBAGIO (Drug) $260.63
  • GOCOVRI (Drug) $251.02
  • SPRIX (Drug) $227.28

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Stuart